AcelRx Pharmaceuticals Inc (ACRX.O)

ACRX.O on Consolidated Issue listed on NASDAQ Global Market

8.86USD
27 Feb 2015
Change (% chg)

$-0.10 (-1.12%)
Prev Close
$8.96
Open
$9.00
Day's High
$9.23
Day's Low
$8.56
Volume
451,317
Avg. Vol
358,024
52-wk High
$13.64
52-wk Low
$5.22

ACRX.O

Chart for ACRX.O

About

AcelRx Pharmaceuticals, Inc. is a development-stage company. It is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of acute and breakthrough pain. The Company’s lead product candidate, Zalviso, formerly Sufentanil NanoTab PCA System (ARX-01), is under review by... (more)

Overall

Beta: 2.06
Market Cap(Mil.): $385.88
Shares Outstanding(Mil.): 44.00
Dividend: --
Yield (%): --

Financials

  ACRX.O Industry Sector
P/E (TTM): -- 175.70 40.21
EPS (TTM): -0.04 -- --
ROI: -2.29 -2.61 16.34
ROE: -3.15 -4.38 17.27
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: ValuEngine, Inc.
$25.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks